Go Pro
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel
NASDAQ:ELAB

PMGC Q2 2024 Earnings Report

PMGC logo
$1.18 0.00 (0.00%)
Closing price 07/2/2026 04:00 PM Eastern
Extended Trading
$1.16 -0.02 (-1.44%)
As of 07/2/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

PMGC EPS Results

Actual EPS
-$9,408.00
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

PMGC Revenue Results

Actual Revenue
$0.61 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

PMGC Announcement Details

Quarter
Q2 2024
Date
8/14/2024
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

PMGC Earnings Headlines

AI, Clinical Data, and Regulatory Catalysts have Wall Street Watching These Biotechs
July 1, 2026  |  usatoday.comhttps://www.usatoday.com/press-release/story/36252/ai-clinical-data-and-regulatory-catalysts-have-wall-street-watching-these-biotechs/
Wall Street is Watching These Biotechs
July 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/01/3320698/0/en/wall-street-is-watching-these-biotechs.html
PH: Do THESE 4 things to your bank account now …
In a few short months, the US government could gain unprecedented powers over personal bank accounts - including the ability to track every transaction or freeze funds. Martin D. Weiss, PhD, founder of Weiss Ratings, has identified 4 simple steps Americans can take today to help safeguard their savings before any changes take effect.tc pixel
July 5 at 1:00 AM  |  Weiss Ratings (Ad)
NorthStrive Biosciences Announces Positive Results from Phase III of AI-Driven Drug Discovery Program with Yuva Biosciences
July 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/01/3320516/0/en/northstrive-biosciences-announces-positive-results-from-phase-iii-of-ai-driven-drug-discovery-program-with-yuva-biosciences.html
Comparing PMGC (NASDAQ:ELAB) & Mitsubishi (OTCMKTS:MSBHF)
June 25, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30860960
NorthStrive Biosciences Files Two New U.S. Patent Applications Targeting Muscle Preservation in GLP-1 and Next-Generation Obesity Treatment Markets
June 18, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/18/3314082/0/en/northstrive-biosciences-files-two-new-u-s-patent-applications-targeting-muscle-preservation-in-glp-1-and-next-generation-obesity-treatment-markets.html
See More PMGC Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like PMGC? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PMGC and other key companies, straight to your email.

About PMGC

Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.

View PMGC Profile
Earnings Tools